Published in Infect Immun on December 01, 1998
Genome sequence of the human malaria parasite Plasmodium falciparum. Nature (2002) 37.89
Draft genome of the filarial nematode parasite Brugia malayi. Science (2007) 5.28
Helminth immunoregulation: the role of parasite secreted proteins in modulating host immunity. Mol Biochem Parasitol (2009) 2.95
A research agenda for helminth diseases of humans: the problem of helminthiases. PLoS Negl Trop Dis (2012) 2.28
Stage- and gender-specific proteomic analysis of Brugia malayi excretory-secretory products. PLoS Negl Trop Dis (2008) 2.06
Brugia malayi excreted/secreted proteins at the host/parasite interface: stage- and gender-specific proteomic profiling. PLoS Negl Trop Dis (2009) 1.88
Intestinal helminth co-infection has a negative impact on both anti-Mycobacterium tuberculosis immunity and clinical response to tuberculosis therapy. Clin Exp Immunol (2007) 1.58
Identification of tgh-2, a filarial nematode homolog of Caenorhabditis elegans daf-7 and human transforming growth factor beta, expressed in microfilarial and adult stages of Brugia malayi. Infect Immun (2000) 1.46
Deworming helminth co-infected individuals for delaying HIV disease progression. Cochrane Database Syst Rev (2009) 1.41
Helminth genomics: The implications for human health. PLoS Negl Trop Dis (2009) 1.26
Functional characterization of the Plasmodium falciparum and P. berghei homologues of macrophage migration inhibitory factor. Infect Immun (2006) 1.23
Stage-specific proteomic expression patterns of the human filarial parasite Brugia malayi and its endosymbiont Wolbachia. Proc Natl Acad Sci U S A (2011) 1.20
Conservation of long-range synteny and microsynteny between the genomes of two distantly related nematodes. Genome Biol (2002) 1.18
Identification of potential vaccine and drug target candidates by expressed sequence tag analysis and immunoscreening of Onchocerca volvulus larval cDNA libraries. Infect Immun (2000) 1.14
Parasite-specific immunomodulatory functions of filarial cystatin. Infect Immun (2003) 1.14
Treatment of helminth co-infection in individuals with HIV-1: A systematic review of the literature. PLoS Negl Trop Dis (2007) 1.14
Structural and functional characterization of a secreted hookworm Macrophage Migration Inhibitory Factor (MIF) that interacts with the human MIF receptor CD74. J Biol Chem (2007) 1.14
Signal sequence analysis of expressed sequence tags from the nematode Nippostrongylus brasiliensis and the evolution of secreted proteins in parasites. Genome Biol (2004) 1.10
A Leishmania ortholog of macrophage migration inhibitory factor modulates host macrophage responses. J Immunol (2008) 1.09
Heterologous expression of the filarial nematode alt gene products reveals their potential to inhibit immune function. BMC Biol (2005) 1.08
Filarial antigens impair the function of human dendritic cells during differentiation. Infect Immun (2001) 1.05
Acquired immune heterogeneity and its sources in human helminth infection. Parasitology (2010) 1.03
Characterization of a Plasmodium falciparum macrophage-migration inhibitory factor homologue. J Infect Dis (2007) 1.01
Orthologs of macrophage migration inhibitory factor from parasitic nematodes. Trends Parasitol (2008) 1.00
Treatment of helminth co-infection in HIV-1 infected individuals in resource-limited settings. Cochrane Database Syst Rev (2008) 0.99
Mice intranasally immunized with a recombinant 16-kilodalton antigen from roundworm Ascaris parasites are protected against larval migration of Ascaris suum. Infect Immun (2003) 0.96
Macrophage migration inhibitory factor of the parasitic nematode Trichinella spiralis. Biochem J (2001) 0.94
MIF homologues from a filarial nematode parasite synergize with IL-4 to induce alternative activation of host macrophages. J Leukoc Biol (2009) 0.91
Intranasal immunization with recombinant Ascaris suum 14-kilodalton antigen coupled with cholera toxin B subunit induces protective immunity to A. suum infection in mice. Infect Immun (2001) 0.90
Thioredoxin from Brugia malayi: defining a 16-kilodalton class of thioredoxins from nematodes. Infect Immun (2003) 0.90
Isolation and characterization of a secretory component of Echinococcus multilocularis metacestodes potentially involved in modulating the host-parasite interface. Infect Immun (2004) 0.86
Tumor-derived macrophage migration inhibitory factor (MIF) inhibits T lymphocyte activation. Cytokine (2006) 0.83
Elevated levels of the Plasmodium yoelii homologue of macrophage migration inhibitory factor attenuate blood-stage malaria. Infect Immun (2010) 0.83
Extract of Nippostrongylus brasiliensis stimulates polyclonal type-2 immunoglobulin response by inducing De novo class switch. Infect Immun (2000) 0.83
Expression of TGF-beta-like molecules in the life cycle of Schistosoma japonicum. Parasitol Res (2005) 0.82
A novel small heat shock protein 12.6 (HSP12.6) from Brugia malayi functions as a human IL-10 receptor binding protein. Mol Biochem Parasitol (2008) 0.82
Structures of Leishmania major orthologues of macrophage migration inhibitory factor. Biochem Biophys Res Commun (2009) 0.82
Gerbu adjuvant modulates the immune response and thus the course of infection in C56BL/6 mice immunised with Echinococcus multilocularis rec14-3-3 protein. Parasitol Res (2010) 0.79
Role of Chemokines and Trafficking of Immune Cells in Parasitic Infections. Curr Immunol Rev (2013) 0.79
Macrophage migration inhibitory factor homolog from Plasmodium yoelii modulates monocyte recruitment and activation in spleen during infection. Parasitol Res (2011) 0.79
Lymphatic filariasis: perspectives on lymphatic remodeling and contractile dysfunction in filarial disease pathogenesis. Microcirculation (2013) 0.78
Comparative analysis of macrophage migration inhibitory factors (MIFs) from the parasitic nematode Onchocerca volvulus and the free-living nematode Caenorhabditis elegans. Parasitol Res (2013) 0.78
Molecular and functional characterization of macrophage migration inhibitory factor (MIF) homolog of human from lymphatic filarial parasite Wuchereria bancrofti. Parasitol Res (2012) 0.77
Identification and expression of macrophage migration inhibitory factor in Sarcoptes scabiei. Exp Parasitol (2013) 0.76
Analysis of the transcriptome of adult Dictyocaulus filaria and comparison with Dictyocaulus viviparus, with a focus on molecules involved in host-parasite interactions. Int J Parasitol (2014) 0.76
Looking beyond the induction of Th2 responses to explain immunomodulation by helminths. Parasite Immunol (2015) 0.76
Various types of Dirofilaria immitis polyproteins selectively induce a Th2-Type immune response. Infect Immun (2003) 0.76
Examining the role of macrolides and host immunity in combatting filarial parasites. Parasit Vectors (2017) 0.75
The non-mammalian MIF superfamily. Immunobiology (2016) 0.75
Comprehensive Transcriptome Meta-analysis to Characterize Host Immune Responses in Helminth Infections. PLoS Negl Trop Dis (2016) 0.75
Signal sequence analysis of protein sequences from the filarial nematode parasite Brugia malayi and the evolution of secreted proteins in parasites. Parasitol Res (2009) 0.75
Helminth Immunomodulation in Autoimmune Disease. Front Immunol (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Basic local alignment search tool. J Mol Biol (1990) 659.07
Improved tools for biological sequence comparison. Proc Natl Acad Sci U S A (1988) 193.60
A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res (1984) 181.98
Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl (1968) 60.35
Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science (1966) 13.12
Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A (1966) 12.29
MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature (1993) 5.60
The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med (1994) 5.55
MIF as a glucocorticoid-induced modulator of cytokine production. Nature (1995) 5.21
Tumour necrosis factor alpha restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice. Nature (1992) 4.57
An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A (1996) 3.79
Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry (1994) 3.58
Growth factor-induced delayed early response genes. Mol Cell Biol (1992) 3.03
Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med (1997) 2.98
Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature (1997) 2.63
Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc Natl Acad Sci U S A (1989) 2.24
The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Mol Med (1996) 2.21
Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset. J Clin Invest (1993) 2.00
Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol (1997) 2.00
An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med (1996) 1.99
Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor. Proc Natl Acad Sci U S A (1996) 1.95
Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J Immunol (1997) 1.86
Crystal structure of the macrophage migration inhibitory factor from rat liver. Nat Struct Biol (1996) 1.75
A macrophage migration inhibitory factor is expressed in the differentiating cells of the eye lens. Proc Natl Acad Sci U S A (1993) 1.54
Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor. EMBO J (1998) 1.52
High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis. J Infect Dis (1996) 1.51
A homolog of interleukin-10 is encoded by the poxvirus orf virus. J Virol (1997) 1.51
Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma. J Clin Invest (1998) 1.46
The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor. J Immunol (1997) 1.46
T-cell activation and the balance of antibody isotypes in human lymphatic filariasis. Parasitol Today (1995) 1.45
Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J Immunol (1998) 1.40
De Novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis. Am J Pathol (1996) 1.40
Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor. Biochemistry (1997) 1.40
Trypanosome invasion of mammalian cells requires activation of the TGF beta signaling pathway. Cell (1995) 1.38
The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase. FEBS Lett (1997) 1.36
Cloning and characterization of the gene for mouse macrophage migration inhibitory factor (MIF). J Immunol (1995) 1.35
Molecular cloning and characterization of onchocystatin, a cysteine proteinase inhibitor of Onchocerca volvulus. J Biol Chem (1992) 1.33
Identification of recombinant filarial proteins capable of inducing polyclonal and antigen-specific IgE and IgG4 antibodies. J Immunol (1995) 1.28
Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor. Proc Natl Acad Sci U S A (1997) 1.28
An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils. J Pharmacol Exp Ther (1989) 1.22
Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor. Proc Natl Acad Sci U S A (1993) 1.19
Genes expressed in Brugia malayi infective third stage larvae. Mol Biochem Parasitol (1996) 1.15
Protective effect on Leishmania major infection of migration inhibitory factor, TNF-alpha, and IFN-gamma administered orally via attenuated Salmonella typhimurium. J Immunol (1998) 1.15
Role of macrophage migration inhibitory factor in the regulation of the immune response. Adv Immunol (1997) 1.12
Stage-specific induction of cytokines regulates the immune response in lymphatic filariasis. Exp Parasitol (1996) 1.10
Thioredoxin peroxidases from Brugia malayi. Mol Biochem Parasitol (1998) 1.09
Functional characterization of the C---C chemokine-like molecules encoded by molluscum contagiosum virus types 1 and 2. Proc Natl Acad Sci U S A (1997) 1.06
A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor-alpha production and expression of B7-1 in human monocyte-derived antigen-presenting cells. Eur J Immunol (1997) 1.06
Identification of macrophage migration inhibitory factor (MIF) in human skin and its immmunohistochemical localization. FEBS Lett (1996) 1.05
Evidence for protective immunity to bancroftian filariasis in the Cook Islands. J Infect Dis (1996) 1.03
Extracellular and cytoplasmic CuZn superoxide dismutases from Brugia lymphatic filarial nematode parasites. Infect Immun (1994) 1.02
Identification of the major soluble cuticular glycoprotein of lymphatic filarial nematode parasites (gp29) as a secretory homolog of glutathione peroxidase. Proc Natl Acad Sci U S A (1992) 1.00
Alteration of macrophage function by a Trypanosoma cruzi membrane mucin. J Immunol (1997) 0.99
The gene for a T lymphocyte triggering factor from African trypanosomes. J Exp Med (1997) 0.99
Secreted poxvirus chemokine binding proteins. J Leukoc Biol (1997) 0.98
A filarial nematode secreted product differentially modulates expression and activation of protein kinase C isoforms in B lymphocytes. J Immunol (1997) 0.98
Thioredoxin peroxidase from Onchocerca volvulus: a major hydrogen peroxide detoxifying enzyme in filarial parasites. Mol Biochem Parasitol (1998) 0.98
Human and rodent interferon-gamma as a growth factor for Trypanosoma brucei. Eur J Immunol (1996) 0.97
Cloning and sequencing of a cDNA encoding rat D-dopachrome tautomerase. FEBS Lett (1995) 0.95
Structure activity studies of the cytokine macrophage migration inhibitory factor (MIF) reveal a critical role for its carboxy terminus. FEBS Lett (1997) 0.93
Evidence for the presence of macrophage migration inhibitory factor in murine reproductive organs and early embryos. Immunol Lett (1996) 0.92
Macrophage migration inhibitory factor in the human ovary: presence in the follicular fluids and production by granulosa cells. Biochem Mol Biol Int (1997) 0.91
A member of the TGF-beta receptor gene family in the parasitic nematode Brugia pahangi. Gene (1997) 0.89
Surface-associated serine-threonine kinase in Schistosoma mansoni. Mol Biochem Parasitol (1995) 0.85
Molecular cloning of a serine proteinase inhibitor from Brugia malayi. Infect Immun (1995) 0.85
Proteolytic cleavage of IgG and other protein substrates by Dirofilaria immitis microfilarial enzymes. J Parasitol (1987) 0.84
The role of macrophage migration inhibitory factor in pregnancy and development of murine embryos. Biochem Mol Biol Int (1996) 0.80
Nucleoside diphosphate kinase from the parasitic nematode Brugia malayi. Gene (1995) 0.80
Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol (2001) 7.40
The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol (1982) 5.78
MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature (1993) 5.60
The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med (1994) 5.55
MIF as a glucocorticoid-induced modulator of cytokine production. Nature (1995) 5.21
Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med (2000) 3.89
An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A (1996) 3.79
Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest (1994) 3.70
Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry (1994) 3.58
Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, endotoxin, and tumor-promoting phorbol diesters. J Immunol (1986) 3.41
Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol (1998) 3.09
Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem (1992) 3.06
Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med (1997) 2.98
Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med (1991) 2.76
An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature (1996) 2.71
Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action. J Biol Chem (1999) 2.60
The Serologic Agglutination of Bacillus Sordellii and Clostridium oedematoides. J Bacteriol (1931) 2.58
Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci U S A (1997) 2.53
Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation (2001) 2.37
The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci U S A (1997) 2.36
The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting. Proc Natl Acad Sci U S A (2003) 2.29
A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun (2002) 2.21
The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Mol Med (1996) 2.21
Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum (1999) 2.17
An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol Med (1999) 2.10
Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci U S A (1997) 2.10
Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc Natl Acad Sci U S A (1992) 2.09
Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci U S A (1994) 2.09
Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene (2007) 2.08
Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells. N Engl J Med (1989) 2.02
Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol (1997) 2.00
An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med (1996) 1.99
Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor. Proc Natl Acad Sci U S A (1996) 1.95
Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J (2001) 1.91
Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J Immunol (1997) 1.86
The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med (1997) 1.86
Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest (1998) 1.85
Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells. J Immunol (1999) 1.83
Role for macrophage migration inhibitory factor in asthma. Proc Natl Acad Sci U S A (2005) 1.79
De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits. Circ Res (2000) 1.78
Human lung mast cells: purification and characterization. J Immunol (1982) 1.78
Generation of leukotrienes by purified human lung mast cells. J Clin Invest (1982) 1.77
Epidemiological studies of leukaemia in children and young adults around nuclear facilities: a critical review. Radiat Prot Dosimetry (2008) 1.77
Abnormal T-cell subset proportions in vitamin-A-deficient children. Lancet (1993) 1.75
An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect. Proc Natl Acad Sci U S A (1999) 1.74
Carboxyl-terminal domain of the Epstein-Barr virus nuclear antigen is highly immunogenic in man. Proc Natl Acad Sci U S A (1985) 1.70
Ras transformation requires metabolic control by 6-phosphofructo-2-kinase. Oncogene (2006) 1.68
Studies on the adhesive interaction between purified human eosinophils and cultured vascular endothelial cells. J Immunol (1988) 1.68
IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol (1995) 1.68
Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study. J Thromb Haemost (2007) 1.67
Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha. J Immunol (1998) 1.63
Long-term assessment of glucose control by haemoglobin-AGE measurement. Lancet (1996) 1.63
Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine. Clin Exp Allergy (2001) 1.63
Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus. Am J Pathol (1993) 1.60
Localization of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland. Mol Med (1995) 1.55
Modification of DNA by reducing sugars: a possible mechanism for nucleic acid aging and age-related dysfunction in gene expression. Proc Natl Acad Sci U S A (1984) 1.55
Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure. Lancet (1994) 1.55
Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol (2000) 1.52
Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. Proc Natl Acad Sci U S A (1998) 1.51
Comparison of clinical, radiologic, and serum marker as prognostic factors after severe head injury. J Trauma (1999) 1.49
Arachidonic acid metabolism in purified human lung mast cells. J Immunol (1984) 1.47
Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma. J Clin Invest (1998) 1.46
The Wolbachia Genome Consortium. Microb Comp Genomics (1999) 1.46
Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils. J Allergy Clin Immunol (2000) 1.46
Episodic eosinophilia-myalgia-like syndrome in a patient without L-tryptophan use: association with eosinophil activation and increased serum levels of granulocyte-macrophage colony-stimulating factor. J Allergy Clin Immunol (1991) 1.45
The Wuchereria bancrofti orthologue of Brugia malayi SXP1 and the diagnosis of bancroftian filariasis. Mol Biochem Parasitol (2000) 1.44
Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation (2001) 1.44
Depressed immune response to tetanus in children with vitamin A deficiency. J Nutr (1992) 1.43
Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence. Genes Immun (2007) 1.43
Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism. Am J Respir Cell Mol Biol (2001) 1.42
BRL 34915 (cromakalim) activates ATP-sensitive K+ current in cardiac muscle. Proc Natl Acad Sci U S A (1988) 1.42
Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo. Mol Med (2000) 1.42
Eosinophils in health and disease: the LIAR hypothesis. Clin Exp Allergy (2010) 1.41
Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. J Clin Invest (1983) 1.41
Mechanisms of dyspnoea relief following radiation treatment in a patient with severe COPD. Eur Respir J (2011) 1.40
Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40
[Transitory hyperinsulinism with hypoglycemia in asphyxia neonatorum]. Arch Pediatr (1997) 1.40
De Novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis. Am J Pathol (1996) 1.40
Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor. Biochemistry (1997) 1.40
Hemoglobin-AGE: a circulating marker of advanced glycosylation. Science (1992) 1.40
Cost utility analysis of radiographic screening for an orbital foreign body before MR imaging. AJNR Am J Neuroradiol (2000) 1.39
Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis Rheum (1998) 1.39
Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES. J Immunol (1994) 1.38
Eosinophil transendothelial migration induced by cytokines. I. Role of endothelial and eosinophil adhesion molecules in IL-1 beta-induced transendothelial migration. J Immunol (1992) 1.38
Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF). Semin Cancer Biol (2000) 1.38
Heterogeneity of human mast cells. J Immunol (1983) 1.37
Macrophage migration inhibitory factor (MIF): a glucocorticoid counter-regulator within the immune system. Crit Rev Immunol (1997) 1.37
Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: possible role in the pathogenesis of malarial anemia. Infect Immun (2000) 1.37
Cloning and characterization of the gene for mouse macrophage migration inhibitory factor (MIF). J Immunol (1995) 1.35
Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am J Pathol (1997) 1.35